China Preclinical Imaging Market Size & Outlook, 2023-2030
China preclinical imaging market, 2018-2030 (US$M)
Related Markets
China preclinical imaging market highlights
- The China preclinical imaging market generated a revenue of USD 252.9 million in 2023 and is expected to reach USD 384.7 million by 2030.
- The China market is expected to grow at a CAGR of 6.2% from 2024 to 2030.
- In terms of segment, optical was the largest revenue generating product in 2023.
- Multi Modal is the most lucrative product segment registering the fastest growth during the forecast period.
Preclinical imaging market data book summary
| Market revenue in 2023 | USD 252.9 million |
| Market revenue in 2030 | USD 384.7 million |
| Growth rate | 6.2% (CAGR from 2023 to 2030) |
| Largest segment | Optical |
| Fastest growing segment | Multi Modal |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CT, MRI, PET/SPECT, Multi Modal, Optical, Ultrasound, Photoacoustic, Reagents, Services |
| Key market players worldwide | Bruker Corp, Siemens AG, GE Aerospace, PerkinElmer, FUJIFILM Holdings Corp, Agilent Technologies, Rigaku, TriFoil Imaging, Mediso Medical Imaging Systems, MR Solutions |
Other key industry trends
- In terms of revenue, China accounted for 5.9% of the global preclinical imaging market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China preclinical imaging market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 384.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Preclinical Imaging Market Scope
Preclinical Imaging Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China preclinical imaging market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to preclinical imaging market will help companies and investors design strategic landscapes.
Optical was the largest segment with a revenue share of 13.4% in 2023. Horizon Databook has segmented the China preclinical imaging market based on ct, mri, pet/spect, multi modal, optical, ultrasound, photoacoustic, reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
Companies interested in entering China should recognize that they must overcome existing barriers in an ambiguous and changing regulatory environment. The country also offers high potential for U.S. companies interested in expanding and entering into the China preclinical imaging market.
China's pharmaceutical and biotechnology industry has been rapidly expanding, with increased investment in research and development activities. Preclinical imaging technologies are essential tools for drug discovery and development, driving their demand within the industry.
There is a growing emphasis on translational research in China, aiming to bridge the gap between preclinical studies and clinical applications. Preclinical imaging plays a crucial role in translating research findings into potential clinical treatments, boosting its demand.
Reasons to subscribe to China preclinical imaging market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China preclinical imaging market databook
-
Our clientele includes a mix of preclinical imaging market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China preclinical imaging market , including forecasts for subscribers. This country databook contains high-level insights into China preclinical imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China preclinical imaging market size, by product, 2018-2030 (US$M)
China Preclinical Imaging Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
